HOOKIPA PHARMA INC. Deferred Tax Assets, Net of Valuation Allowance
HOOKIPA PHARMA INC. had Deferred Tax Assets, Net of Valuation Allowance of $4.49 million as of 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2025-02-28
- 2024-12-31: Deferred Tax Assets, Net of Valuation Allowance $4.49M.
- 2023-12-31: Deferred Tax Assets, Net of Valuation Allowance $5.05M.
- 2022-12-31: Deferred Tax Assets, Net of Valuation Allowance $4.38M.
- 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $5.04M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2024-12-31 | $4.49M 10-K · filed 2025-02-28 |
| 2023-12-31 | $5.05M 10-K · filed 2025-02-28 |
| 2022-12-31 | $4.38M 10-K · filed 2024-03-22 |
| 2021-12-31 | $5.04M 10-K · filed 2023-03-15 |
| 2020-12-31 | $1.87M 10-K · filed 2022-03-24 |
| 2019-12-31 | $2.04M 10-K · filed 2021-03-18 |